Latest Als News

Page 20 of 21
Control Bionics has delivered its strongest US sales quarter in years, nearing US$1 million in revenue, while broadening its market footprint with new commercial agreements and cost optimizations.
Ada Torres
Ada Torres
31 Jan 2025
SRJ Technologies reported a remarkable 178% increase in Q4 FY24 cash receipts, driven by strong contract activity and strategic partnerships, including a key Middle East market entry. Despite some project delays, the company remains confident in its growth trajectory for FY25.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Advanced Health Intelligence Ltd has locked in a USD$4 million convertible note facility with UAE-based KOR Investments LLC, aiming to raise up to AUD$10 million to fuel its MENA expansion and reduce debt.
Ada Torres
Ada Torres
30 Jan 2025
Alara Resources reports significant copper mineralisation discoveries in Oman’s Block 8, with initial assays revealing grades up to 4.46% Cu, setting the stage for intensified exploration alongside Power Metal Resources.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Tesoro Gold reports its highest-ever gold assay at the Ternera Deposit alongside a strategic dual listing on the Frankfurt Stock Exchange and a strong cash position.
Maxwell Dee
Maxwell Dee
30 Jan 2025
OncoSil Medical has secured new distribution agreements across key international markets and achieved critical regulatory milestones, while raising $8 million to fuel its growth in pancreatic cancer treatment.
Victor Sage
Victor Sage
30 Jan 2025
Rincon Resources has identified a promising new copper target at its West Arunta project and is progressing mineral resource estimations at South Telfer, underpinning a busy exploration quarter with $3.342 million cash in hand.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Belararox Limited has validated the presence of a copper porphyry system at its Malambo prospect in Argentina through recent geophysical surveys, setting the stage for an imminent drilling campaign.
Maxwell Dee
Maxwell Dee
29 Jan 2025
Neurizon Therapeutics reports encouraging 8-month interim results for its ALS drug NUZ-001, secures Orphan Medicinal Product Designation in Europe, and raises $885,000 through a share placement, maintaining a robust $14 million cash position.
Ada Torres
Ada Torres
29 Jan 2025
Algorae Pharmaceuticals reports robust progress in its drug development pipeline, highlighted by promising preclinical results for cardiovascular and dementia candidates and significant AI platform enhancements.
Victor Sage
Victor Sage
29 Jan 2025
Great Dirt Resources Ltd. has confirmed significant manganese mineralisation at its Junior Prospect in NSW, revealing promising high-grade zones and multiple stacked lodes that could substantially boost the project's resource potential.
Maxwell Dee
Maxwell Dee
28 Jan 2025
Rox Resources has advanced its Youanmi Gold Project with a $27 million capital raise and a major drilling campaign, positioning the company for production by late 2025.
Maxwell Dee
Maxwell Dee
28 Jan 2025